Home >> Company >> Advisors

Professor Arnold Kriegstein
Dr. Kriegstein is the John Bowes Distinguished Professor in Stem Cell and Tissue Biology and Founding Director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF. Dr. Kriegstein received a BS from Yale University (1971), and MD and PhD from New York University (1977). He completed Neurology Residenc
Professor Arash Komeili
Professor Komeili is an Associate Professor of Microbiology in the Department of Plant and Microbial Biology at the University of California, Berkeley. He received his undergraduate degree in Biology from the Massachusetts Institute of Technology in 1996, Ph. D. in Cell Biology from the University of California, San Francisco in 2001 and
Professor Daniel Portnoy
Dr. Portnoy is a Professor and Edward E. Penhoet Distinguished Chair in Global Public Health and Infectious Diseases at UC Berkeley with joint appointments in the Divisions of Biochemistry Biophysics, and Structural Biology, Division of Immunology and Pathogenesis, Infectious Diseases and Vaccinology, and Microbial
Professor Chris Contag
Dr. Contag, is a Professor in the Departments of Pediatrics, Radiology and Microbiology & Immunology at Stanford University, and a member of the BioX Faculty for interdisciplinary sciences, and the Immunology Faculty. Dr. Contag received his B.S. in Biology from the University of Minnesota, St. Paul in 1982. He received his Ph.D. in M
Professor Ian McNiece
Dr. McNiece received his Ph.D. in physiology in 1986 from the University of Melbourne undertaking his thesis work at the Peter MacCallum Cancer Institute. He moved to the US in 1986 as a postdoctoral fellow at the University of Virginia, Charlottesville, Virginia. In 1988 he moved to Thousand Oaks, California to join Amgen Inc. as a Resea
Professor Edward E. Graves
Professor Graves joined the Department of Radiation Oncology in the Stanford University School of Medicine in 2003 as an Assistant Professor in the Division of Radiation Physics, and was promoted to Associate Professor with Tenure in 2012. He trained in Bioengineering at the University of California at Berkeley (B.S., 1996) and the Univer
Professor Paul Yaswen
Dr. Yaswen is a Staff Scientist in Lawrence Berkeley National Laboratory. He has over two decades of experience in cancer research, with numerous publications in top-tier scientific journals. His lab currently focuses on developmental pathways that govern oncogenic transformation and immortalization of human mammary epithelial cells. Key
Dr. Todd Peterson, Ph.D.
Dr. Peterson is currently the Chief Technology Officer of Synthetic Genomics, and brings significant experience in the synthetic biology space.  Todd has more than 25 years of research leadership in the genomics, diagnostics and synthetic biology space.  He completed his Ph.D. in microbiology from the University of Southern Cali
Contact Us Sitemap Terms of Use
Follow Bell Biosystems
© 2018 Bell Biosystems. All rights are reserved
Website Security Test